Hossein Rahimi

604 total citations
37 papers, 391 citations indexed

About

Hossein Rahimi is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Hossein Rahimi has authored 37 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Hossein Rahimi's work include Lymphoma Diagnosis and Treatment (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and CRISPR and Genetic Engineering (4 papers). Hossein Rahimi is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and CRISPR and Genetic Engineering (4 papers). Hossein Rahimi collaborates with scholars based in Iran, Türkiye and United States. Hossein Rahimi's co-authors include Hossein Danafar, Hamed Nosrati, Marziyeh Salehiabar, Mohammadreza Ghaffarlou, Murat Barsbay, Saeed Kaboli, Soodabeh Davaran, Taras Kavetskyy, Ali Sharafi and João Conde and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Gene.

In The Last Decade

Hossein Rahimi

27 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hossein Rahimi Iran 9 193 145 102 52 37 37 391
Mingyuan Zou China 11 218 1.1× 134 0.9× 51 0.5× 40 0.8× 32 0.9× 33 427
Luiza I. Hernandez Spain 13 512 2.7× 214 1.5× 62 0.6× 47 0.9× 36 1.0× 17 654
Fengfei Xie China 10 164 0.8× 96 0.7× 45 0.4× 66 1.3× 24 0.6× 14 339
Patricia K. Russ United States 12 300 1.6× 189 1.3× 62 0.6× 25 0.5× 49 1.3× 16 527
Aram Kang South Korea 14 203 1.1× 82 0.6× 106 1.0× 31 0.6× 48 1.3× 31 535
Dushyant Jahagirdar Canada 12 204 1.1× 72 0.5× 33 0.3× 43 0.8× 37 1.0× 17 314
Frank A. Veliz United States 11 109 0.6× 105 0.7× 75 0.7× 65 1.3× 28 0.8× 14 450
Mi Qi China 7 130 0.7× 68 0.5× 78 0.8× 46 0.9× 24 0.6× 8 344
Xiao‐Ting Xie China 13 152 0.8× 206 1.4× 41 0.4× 77 1.5× 123 3.3× 43 472
Elizabeth J. Curvino United States 7 227 1.2× 83 0.6× 50 0.5× 94 1.8× 25 0.7× 9 413

Countries citing papers authored by Hossein Rahimi

Since Specialization
Citations

This map shows the geographic impact of Hossein Rahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hossein Rahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hossein Rahimi more than expected).

Fields of papers citing papers by Hossein Rahimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hossein Rahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hossein Rahimi. The network helps show where Hossein Rahimi may publish in the future.

Co-authorship network of co-authors of Hossein Rahimi

This figure shows the co-authorship network connecting the top 25 collaborators of Hossein Rahimi. A scholar is included among the top collaborators of Hossein Rahimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hossein Rahimi. Hossein Rahimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahimi, Hossein, et al.. (2025). Integrative Systems Biology Analysis of MicroRNA Regulation in Wnt Signaling Pathway During Breast Cancer Progression. International Journal of Cancer Management. 18(1).
2.
Bos, Mettine H.A., et al.. (2025). Subgaleal Hematoma in a Female With Normal Coagulation Tests. Case Reports in Hematology. 2025(1). 5481806–5481806.
3.
Rahimi, Hossein, et al.. (2025). A Comprehensive Review on Anticancer Potential of Pulicaria Plants and their Derivatives. Current Cancer Drug Targets. 25(10). 1210–1221. 1 indexed citations
4.
Rahimi, Hossein, et al.. (2025). A Review of Anticancer Activity of Ferula Constituents and their Action Mechanism. Current Pharmaceutical Design. 31(30). 2402–2415.
5.
Sharafi, Mohsen, et al.. (2025). Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression. Clinical and Experimental Medicine. 25(1). 237–237. 1 indexed citations
6.
Naseri, Zahra, et al.. (2024). Approaches of wearable and implantable biosensor towards of developing in precision medicine. Frontiers in Medicine. 11. 1390634–1390634. 21 indexed citations
7.
8.
Rahimi, Hossein, et al.. (2023). Comparison of bolus administration and short-term infusion versus long-term infusion of doxorubicin in terms of cardiotoxicity and efficacy. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(6). 3771–3780. 2 indexed citations
9.
Ghavami, Vahid, et al.. (2023). The evaluation of atorvastatin as an adjunct to fluconazole for the anti-fungal prophylaxis in acute myeloid leukemia: a multicenter, triple-blinded, randomized clinical trial. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(6). 4355–4364. 1 indexed citations
10.
Abedi, Farshad, et al.. (2022). The Effect of Heparin and Its Preparations on Disseminated Intravascular Coagulation Mortality and Hospitalization: A Systematic Review. International Journal of Clinical Practice. 2022(1). 2226761–2226761. 4 indexed citations
11.
Rahimi, Hossein, Jose Thekkiniath, Behrooz Johari, et al.. (2022). BSA-PEI Nanoparticle Mediated Efficient Delivery of CRISPR/Cas9 into MDA-MB-231 Cells. Molecular Biotechnology. 64(12). 1376–1387. 12 indexed citations
12.
Salehiabar, Marziyeh, Mohammadreza Ghaffarlou, Ali Mohammadi, et al.. (2022). Targeted CuFe2O4 hybrid nanoradiosensitizers for synchronous chemoradiotherapy. Journal of Controlled Release. 353. 850–863. 39 indexed citations
13.
Samadi, Sara, et al.. (2022). Aprepitant, fosaprepitant and risk of ifosfamide-induced neurotoxicity: a systematic review. Cancer Chemotherapy and Pharmacology. 90(1). 1–6. 6 indexed citations
14.
15.
Bahrami, Ahmad Reza, et al.. (2021). Investigating the association between rs6983267 polymorphism and susceptibility to gastrointestinal cancers in Iranian population. Molecular Biology Reports. 48(3). 2273–2284. 3 indexed citations
16.
Rahimi, Hossein, Marziyeh Salehiabar, Murat Barsbay, et al.. (2021). CRISPR Systems for COVID-19 Diagnosis. ACS Sensors. 6(4). 1430–1445. 110 indexed citations
17.
Mozdourian, Mahnaz, et al.. (2020). Investigation of hematological parameters related to the severity of COVID-19 disease in Mashhad, Iran. SHILAP Revista de lepidopterología. 7(2). e19–e19. 6 indexed citations
18.
Rahimi, Hossein, et al.. (2015). Evaluation of BCL6 and MUM1 Expression in Patients with Diffuse Large B Cell Lymphoma (DLBCL) and Their Correlation with Staging and Prognosis of the Disease. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Rahimi, Hossein, et al.. (2014). Effects of weed management strategies on weed density and biomass and saffron (Crocus sativus) yield. SHILAP Revista de lepidopterología. 2 indexed citations
20.
Rahimi, Hossein, et al.. (2011). IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingyuan Zou Breakdown of academic impact, for papers by Luiza I. Hernandez Breakdown of academic impact, for papers by Fengfei Xie Breakdown of academic impact, for papers by Patricia K. Russ Breakdown of academic impact, for papers by Aram Kang Breakdown of academic impact, for papers by Dushyant Jahagirdar Breakdown of academic impact, for papers by Frank A. Veliz Breakdown of academic impact, for papers by Mi Qi Breakdown of academic impact, for papers by Xiao‐Ting Xie Breakdown of academic impact, for papers by Elizabeth J. Curvino
Rankless by CCL
2026